Conferences with our Presentations and Abstracts
31st Charles B. Huggins Research Symposium, Chicago, IL
Lin W. Novel Desensitization Therapy with Carfilzomib/Bortezomib and Belatacept for Highly Sensitized Kidney Transplant Candidates: Preliminary Outcomes. Abstract
Gondek S. Achieving Insulin Independence in Humans through Stem Cell-Derived Islet Cell Transplantation: Preliminary Insights from the VX-880 Multicenter Clinical Trial Abstract
Tomecki J. A Insight from the Initial Patient Cohort: Islet Allotransplantation into Pre-vascularized Sernova Cell Pouch. Abstract
Juengel B. Customizing Abdominal Incision Approaches Based on Patient Age for Minimizing Surgical Would Complications in Single Kindey Transplants. Abstract
Bachul P. Aiming for Optimal Immunosuppression in Islet Transplantation: Assessing the Tolerability and Efficacy of Belatacept in Conjunction with Reduced Tacrolimus. Abstract
International Pancreas and Islet Transplantation Association Congress, San Diego, CA
Lin W. Timing of anti-thymocyte globulin infusion affects islet engraftment after intraportal allotransplantation in patients with T1DM. Abstract
Gondek S. Pancreas after islet and islet after pancreas transplantation offer a durable insulin independence to patients with type 1 diabetes mellitus and problematic hypoglycemia Abstract
Lin W. Insulin independence after intraportal islet transplantation in patients with kidney allograft and type 1 diabetes mellitus. Abstract
Witkowski P. Glucose-Dependent Insulin Production and Insulin-Independence in Type 1 Diabetes from Stem Cell-Derived, Fully Differentiated Islet Cells: Updated Data from the VX-880 Clinical Study. Abstract
Witkowski P. Emerging data from a study of tegoprubart for the prevention of rejection in kidney transplant recipients: Implications for a similar study in islet cell transplantation. Abstract
4th Polish American Youth Academic Summit, Chicago
Shuckla S. Utility of Plasmapheresis and Intensified Immunosuppressive therapy for de novo HLA Antibodies in Patients after Pancreatic Islet Transplantation. The University of Chicago experience- 2nd Oral Presentation Award. Abstract
Milejczyk K. Pancreas after islet as well as islet after pancreas transplantation offer durable insulin independence to patients with diabetes mellitus and problematic hypoglycemia. 3rd Oral Presentation Award. Abstract
Gondek S. Long term effects of pancreatic islets transplantation on polyneuropathy in patients with brittle diabetes: a single center experience. 3nd Poster Presentation Award. Abstract
Lin W. Pain and Blood Glucose Control after Total Pancreatectomy and Islet Autotransplantation in Patients with Chronic Pancreatitis- 9 year follow up. Abstract
Tomecki J. Persistence of Long-term Insulin Independence After Islet Transplantation and Two Subsequent Pregnancies. Abstract
Scientific Sessions, American Diabetes Association, San Diego CA
Ogledzinski M. Islet Allotransplantation into Pre-vascularized Sernova Cell Pouch™ - Early Results from the University of Chicago- oral presentation
Lin W. Preservation of Islet Graft Function and Blood Glucose Control after Total Pancreatectomy with Islet Autotransplantation in patients with Chronic Pancreatitis and intractable pain- 9 year follow up. -oral presentation
Gondek S. Preemptive Insulin Supplementation for Islet Graft Protection, Optimal Blood Glucose Control, and Fetal Development during the Pregnancy in Insulin-Independent Patient after Islet Transplantation.
Reichman T. Glucose-Dependent Insulin Production and Insulin-Independence in Type 1 Diabetes from Stem Cell-Derived, Fully Differentiated Islet Cells (VX-880): Update on the 7 Enrolled Trial Participants.
ASTS Winter Symposium, Miami FL
Ogledzinski M. Islet After Kidney Transplantation Restores Insulin Independence In Patients With Type 1 Diabetes.
Ogledzinski M. Successful pancreas after islet and islet after pancreas transplantation for patients with diabetes mellitus and problematic hypoglycemia.
The Transplantation Society Congress, Buenos Aires, Argentina
Bachul P. Successful islet after pancreas and pancreas after islet transplantation for patients with diabetes mellitus and problematic hypoglycemia.
Bachul P..
Modified Approach Allowed for Improved Islet Allotransplantation Into Pre-vascularized Sernova Cell PouchTM Device - Preliminary Results of the Phase I/II Clinical Trial at University of Chicago
Scientific Sessions American Diabetes Association
Markman JF, Stem cell-derived, fully differentiated islet cells for T1DM.
Bachul P. Successful islet after pancreas and pancreas after islet transplantation for patients with diabetes mellitus and problematic hypoglycemia.
Bachul P, Effectiveness Of Covid-19 Vaccination In The Islet Transplant Recipients. Young Investigator Award. American Diabetes Association, 2022.
International Pancreas and Islet Transplantation Association Congress
Bachul P. Favorable 5-year Follow Up Outcomes After Islet Transplantation in Patients With Type 1 Diabetes Mellitus at University of Chicago
Bachul P.. Modified Approach Allowed for Improved Islet Allotransplantation Into Pre-vascularized Sernova Cell PouchTM Device - Preliminary Results of the Phase I/II Clinical Trial at University of Chicago
American Transplant Congress
Jayant K. The Impact of Covid-19 in Kidney Transplant Recipients: A Systematic Review and Meta-analysis (oral)
Jayant K. Analyzing the Impact of Covid-19 in the Hospitalized Cohort of Liver Transplant Recipients: An Early Systematic Review and Meta-Analysis..
American Transplant Congress
Jayant K. The Impact of Covid-19 in Kidney Transplant Recipients: A Systematic Review and Meta-analysis (oral)
Jayant K. Analyzing the Impact of Covid-19 in the Hospitalized Cohort of Liver Transplant Recipients: An Early Systematic Review and Meta-Analysis..
American Society of Transplant Surgeons Winter Symposium
Bachul PJ. Islet Allotransplantation Into Pre-Vascularized Sernova Cell PouchTM - Preliminary Results From The University of Chicago.
Generette G. Anterior Rectus Sheath Versus Gibson Incision For Kidney Transplantation -Preliminary Experience.
28th International Congress of The Transplantation Society
Bachul PJ. Durable effect of beta cell replacement therapy on improvement in blood glucose control and prevention of progression of secondary diabetic complications in nonuremic patients with type 1 diabetes mellitus and problematic hypoglycemia
American Transplant Congress,
Bachul PJ. Total pancreatectomy with islet autotransplantation in diabetic and prediabetic patients with intractable chronic pancreatitis
Bachul PJ. Beta Cell Replacement Therapy in Nonuremic Patients with Brittle T1DM allows for durable long term insulin independence halting progression of secondary diabetic complications.
Bachul PJ. Successful Transplantation of the Kidney Graft with 5 Arteries and Intimal Dissection Injury - 9 year follow up.
27th Annual Charles B. Huggins Research Symposium
Bachul PJ. Successful Treatment of Complete Portal Vein Thrombosis (PVT) after Total Pancreatectomy with Islet Autotransplantation (TP-IAT) with Intraportal Thrombolysis and Transjugular Intrahepatic Porto-Systemic Shunt (TIPS)
Stepinska G. ‘En Bloc’ Liver and Pancreas Transplantation in Patient with Chronic Pancreatitis, Liver Disease and Previous Auto-Islet Transplantation and What We Learned from It
8th European Pancreas and Islet Transplantation Association (EPITA)
Winter Symposium
Golebiewska J. Preliminary results of islet after kidney transplantations from the new islet transplantation program at Medical University of Gdansk in Poland. (GUMED/CELLT).
Bugajska-Liedtke M. Utility of the North American Islet Donor Score and Islet Donor Scores for Pancreas Donor Selection and Successful Islet Isolation in a new Polish Islet Transplant Center. (CELLT/GUMED)
American Society of Transplant Surgeons
ASTS Winter Symposium, Miami, FL
Fillman N. Does CXCL8 inhibitor (Reparixin) improve islet engraftment and clinical outcomes after islet allotransplantation? University of Chicago preliminary results from a phase 3 multicenter randomized, double-blinded, prospective study.
selected for oral presentation
8th EPITA Symposium
Innsbruck, Austria
Golebiewska J. Does CXCL8 inhibitor (Reparixin) improve islet engraftment and clinical outcomes after islet allotransplantation? University of Chicago preliminary results from a phase 3 multicenter randomized, double-blinded, prospective study.
selected for oral presentation
26th Annual Charles B. Huggins Symposium, Chicago, IL
1. Para M/ Damian Grybkowski. Pain resolution and glycemic control in pediatric patients after total pancreatectomy with islet cell autotransplantation for chronic pancreatitis.- selected for oral presentation.
2. Antic F. Is there any Prognostic Value of Diabetes-Associated Autoantibody Levels for Predicting Islet Graft Function in Patients with Long-Standing Type 1 Diabetes Mellitus?
3. Bachul P. Does a new CXCR8 inhibitor (Reparixin) improve islet cell engraftment and clinical outcomes after pancreatic islet allotransplantation in patients with type 1 diabetes mellitus? A randomized, double blind, prospective study.
American Transplant Congress
Boston, MA
Bachul P. Does the Reparixin (CXCR1/2 Inhibitor) Improve Islet Cell Engraftment and Clinical Outcomes after Pancreatic Islet Allotransplantation in Patients with Type 1 Diabetes Mellitus? A Randomized, Double-Blind, Prospective Study.
Perez Gutierrez A. KDPI Significantly Correlates With Reperfusion Biopsy Findings
American Diabetes Association,
79th Scientific Sessions, San Francisco, CA
Oral presentations:
1. Grybowski D. BETA-2 Calculated Based on Single Fasting Blood Sample Allows to Define and Discriminate between Optimal and Suboptimal Islet Allograft Function Prior to the Clinical Need for Insulin Support. Read Link
2. Bachul P. Does the Reparixin (CXCR1/2 Inhibitor) Improve Islet Cell Engraftment and Clinical Outcomes after Pancreatic Islet Allotransplantation in Patients with Type 1 Diabetes Mellitus? A Randomized, Double-Blind, Prospective Study. Read Link
3. Anteby R/Luncander A. Is There Any Prognostic Value of Diabetes-Associated Autoantibody Levels for Predicting Islet Graft Function in Patients with Long-Standing Type 1 Diabetes Mellitus? Read Link
International Pancreas and Islet Transplantation Association
17th World Congress, Lyon, France
Oral presentations:
1. P Bachul. Is there any Prognostic Value of Diabetes-Associated Autoantibody Levels for Predicting Islet Graft Function in Patients with Long-Standing Type 1 Diabetes Mellitus?
2. Golebiewska. BETA-2 Based On Single Fasting Blood Sample Allows To Define and Discriminate Optimal And Suboptimal Islet Allograft Function Prior to The Need For Reintroduction of Insulin Support.
3. Bachul P. Does A CXCR1/2 Inhibitor (Reparixin) Improve Islet Cell Engraftment And Clinical Outcomes After Pancreatic Islet Allotransplantation In Patients With Type 1 Diabetes Mellitus? Results of A Randomized, Double Blind, Prospective Study from the University of Chicago.
4. Golebiewska J. Utilization of an "old school" supplemental purification technique allowed safe intraportal pancreatic islet transplantation. The first case ofislet allotransplantation in Medical University of Gdańsk, Poland.
5. Bellin M. A Randomized and Blinded Trial of Infusion of the CXCL8-inhibitor Reparixin in Autologous Islet Transplant Recipients.
8th EPITA Symposium
Innsbruck, Austria
1. Golebiewska J. Assessment of simple indices based on a single fasting blood sample in search for an optimal tool to estimate beta cell function after total pancreatectomy with islet autotransplantation.
2. Bachul P. BETA-2 score for early detection of islet allograft decline and monitoring of islet function
The 25th Annual Charles Huggins Research Symposium
UCMC, Chicago, IL
1. Bachul P. Estimation of beta cell function after total pancreatectomy with islet autotransplantation using single fasting blood sample based indices and modified Igls score
2. Fillman N. External validation of the newly developed BETA-2 scoring system for pancreatic islet graft function assessment
3. Fillman N. BETA-2 score is an excellent tool for monitoring of islet allograft function and early detection of transplant dysfunction
4. Kijek M. Pain resolution with good glucose control in pediatric patients with chronic pancreatitis after total pancreatectomy with islet cell autotransplantation
5. Kijek M. Broad Non-Neuraxial Analgesia Reduces Risk of Portal Vein Thrombosis After Total Pancreatectomy and Autologous Islet Transplantation Comparing to the Neuraxial Analgesia with the adequate postoperative pain control
6. Pavelko Y. Early infectious complications post total pancreatectomy with islet autotransplantation
American Transplant Congress (ATC)
Seattle, WA
1. Golebiewska J. Early infectious complications post total pancreatectomy with islet autotransplantation. READ
2. Golebiewska J. Estimation of beta cell function after total pancreatectomy with islet autotransplantation using single fasting blood sample based indices and modified Igls score
3. Bachul P. BETA-2 score is an excellent tool for monitoring of islet allograft function and early detection of transplant dysfunction
27th International Congress of The Transplantation Society (TTS) Madrid, Spain
1. Golebiewska J. Comparative evaluation of simple indices using a single fasting blood sample to estimate beta cell function after total pancreatectomy with islet autotransplantation
2. Golebiewska J. Early infectious complications post total pancreatectomy with islet autotransplantation. READ
3. Bachul P. BETA-2 score allows for convenient and precise monitoring of islet function and early detection of islet dysfunction